PKM and Parkinson disease: Dimerization of PKM2 can promote the dopamine D2 receptor (DRD2) in astrocytes to promote dopamine biosynthesis through GSH synthesis regulated by PKM2-mediated Nrf2 transactivation, thus providing a potential target for Parkinson’s disease (58).